“Secukinumab Provides Complete or Almost-Complete Psoriasis Clearance in Moderate-to-Severe Plaque Psoriasis: Pooled Analysis of 4 Phase 3 Trials” (2018) SKIN The Journal of Cutaneous Medicine, 2(S1), p. S19. doi:10.25251/skin.2.supp.19.